Elastin3 for Stretch Marks: Evidence Review

Elastin3 is a topical cosmetic product marketed for stretch marks (striae distensae). Its formulation typically includes hydrolyzed elastin, collagen, peptides, and botanical extracts.

Current Evidence

  • No peer-reviewed, randomized controlled trials (RCTs) specifically evaluating Elastin3 for striae reduction exist in PubMed/Embase as of 2024.
  • Manufacturer claims are based on ingredient-level data (e.g., elastin peptides may stimulate fibroblast elastin synthesis in vitro) and anecdotal/user-reported outcomes.
  • General topical therapy evidence: Tretinoin (retinoic acid) 0.05–0.1% has the strongest evidence for early striae rubra (red). Hyaluronic acid, centella asiatica, and glycolic acid show modest benefit in small studies. Mature striae alba (white) respond poorly to topicals.

Mechanistic Plausibility vs. Clinical Reality

Stretch marks are dermal scars with disrupted collagen/elastin architecture, loss of rete ridges, and epidermal atrophy. Topical agents poorly penetrate to the deep dermis where pathology resides. Procedures (fractional laser, microneedling RF, radiofrequency) have superior evidence by inducing controlled injury and neocollagenesis.

Recommendation

  • For striae rubra (early, red): Prescription tretinoin + moisturizer is first-line evidence-based topical.
  • For striae alba (mature, white): Topicals have minimal effect. Consider procedural options.
  • Elastin3 may provide hydration and temporary cosmetic improvement but should not be relied upon as primary treatment. Discuss with a dermatologist for personalized plan.

Muscle Strains - Related Articles